An interventional study of Perceive, Recall, Plan and Perform (PRPP) evaluation in Mental Health, Aging Disorder and Psychiatric Disorder, sponsored by Centre Hospitalier Charles Perrens, Bordeaux. Recruiting at 1 site in France. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-16.
Sponsored by Centre Hospitalier Charles Perrens, Bordeaux · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Over the past 30 years, mental health policy has been geared towards increasing the number of people receiving care in the community, with a reduction of over 50% in the number of general psychiatric beds. The WHO recommends the implementation of alternatives to hospitalization, through the development of outpatient and home-based psychiatric care programs that support independent living.
People suffering from psychiatric disorders show cognitive decline as they age, including deficits in perception, attention, memory and problem-solving. These cognitive problems affect the ability to carry out the tasks of daily life, and make it more difficult to remain at home. In order to avoid hospitalization for these psychiatrically-stabilized patients who are losing their autonomy, it is necessary to take into account their mental and cognitive handicap, and to provide them with appropriate compensation.
Occupational therapy is a discipline concerned with the assessment, rehabilitation and integration of people with disabilities. Occupational therapists provide ecological assessments to support personalized care plans. The PRPP (Perceive, Recall, Plan and Perform) task analysis system is a validated, ecological tool that integrates an occupational therapy assessment and intervention model. The PRPP assessment measures occupational performance and the impact of cognitive impairments on information processing and on the cognitive strategies required to carry out activities. Research conducted in Canada illustrates the value of PRPP in supporting people with schizophrenia. To the best of our knowledge, no team has studied the use of PRPP in the decision-making process for maintaining people with aging psychiatric disorders (PATPV) at home.
The main hypothesis is that the use of the PRPP, through its scientific validity, will facilitate the decision-making of multi-professional care teams for the ambulatory support of PATPV to support :
This is a prospective, single-center study conducted within the "pathologies, handicap and aging" unit of the General and University Psychiatry (PGU) cluster at the Charles Perrens Hospital in Bordeaux.
The "pathologies, disability and aging" unit is dedicated to addressing the loss of autonomy and disability of people suffering from severe psychiatric disorders. One of its aims is to prevent hospitalization, particularly long-term hospitalization, for patients with chronic psychiatric pathologies who have become care-dependent. The program is structured around a multi-professional mobile team in charge of assessments, and a day hospital providing outpatient psychosocial rehabilitation care.
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's planned enrollment of 66 is below the median of 100 across 1,305 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →Centre Hospitalier Charles Perrens, Bordeaux is the lead sponsor of 19 studies on the registry; 12 are open to participants now.
Compared within Mental Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
T0 to T3 months: Evaluations * Multi-professional assessment by mobile team or day hospital * Completion of PRPP on 2 activities T3 months: First referral \- Decision on the participant's future orientation following the PRPP T3 months to T9 months: Outpatient psychosocial rehabilitation (standard care) * Personalized psychosocial rehabilitation program determined in part by the PRPP and carried out in the day hospital for all participants. * PRPP interventions (occupational therapy) T9 months: Reassessment and confirmation of orientation * Second round of PRPP based on activities assessed at T3 months * Questionnaires to help with referral decisions, completed by the multi-professional teams involved in the program, and by the treating psychiatrist after the second PRPP has been completed.
Behavioral: Perceive, Recall, Plan and Perform (PRPP) evaluation
Passing the PRPP for 2 activities
Efficiency of the PRPP system for living orientation
Scoring the PRPP system for monitoring changes in occupational performance following the implementation of a personalized psycho-social rehabilitation project.
Time frame: 9 months after inclusion
Number of hospitalizations since inclusion
Counting the number of hospitalizations
Time frame: 12 months after inclusion
Plan to share: No
Started Dec 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.
Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 24 months is below that.
Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Charles Perrens, Bordeaux